AKTIS ONCOLOGY INC (AKTS) insider trading activity (SEC Form 4). Over the trailing 90 days, AKTS insiders filed 0 purchases totalling $0 and 1 sales totalling $259K — net SELLING of $259K. Most recent filing: Sep 24, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | Czibere Akos | Chief Medical Officer | S SaleOE | — | $20.69 | $259K | filing |
| Jul 21, 2026 | Herrmann Ken | Dir | S SaleOE | — | $24.56 | $119K | filing |
| Jul 20, 2026 | Herrmann Ken | Dir | S SaleOE | — | $25.21 | $77K | filing |
| Jul 10, 2026 | Ron-Bigger Shulamit | COO | S SaleOE | — | $27.75 | $1.4M | filing |
| Jul 10, 2026 | Czibere Akos | Chief Medical Officer | S SaleOE | — | $27.77 | $1.4M | filing |